Synthesis, Stability, and Anti-Tumour Activity of a New Category of "Stapled" Antisense Oligonucleotides with Stimuli-Responsive Feature.

Journal of Pharmaceutical Sciences
Hongqian RenLiang Xu

Abstract

The development of nucleic acid drugs with unique structures and mechanisms has stimulated great research interest. Herein, we report a general strategy to construct "stapled" structures of single-stranded antisense oligonucleotides (ASONs) with a stimuli-responsive feature. "Stapled" cyclic structures can be synthesized with reactive bifunctional handles that react with thiol groups of phosphorothioate (PS)-modified ASONs, and can be alternatively adjusted depending on the desired PS sites in the ASON strand. The disulphide group in the stapled handle can be cleaved in the reducing microenvironment of tumour cells. Thus, "stapled" ASONs may be transformed back to a linear conformation to facilitate binding to target mRNAs. Stapling conferred protection against degradation, and enhanced anti-tumour activity compared to linear counterparts. This study provides a new, effective, and convenient strategy for designing ASONs with "stapled" structures, and also adds a further contribution to facilitate the stability and biological efficacy of novel nucleic acid-based therapeutics.

References

May 15, 1987·Archives of Biochemistry and Biophysics·Q S WangJ T Wong
Aug 24, 2004·The Journal of Biological Chemistry·Daniel A Di Giusto, Garry C King
Apr 9, 2005·Nucleic Acids Research·Daniel A Di GiustoGarry C King
Jun 26, 2009·Expert Opinion on Drug Delivery·Xiubo ZhaoJian R Lu
Jul 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Gregory H BirdLoren D Walensky
Jul 4, 2012·Topics in Current Chemistry·Phong Lan Thao TranJean-Louis Mergny
Feb 11, 2015·Nucleic Acids Research·Sonja Petkovic, Sabine Müller
Jul 15, 2015·Human Gene Therapy·Karin E LundinC I Edvard Smith
Oct 30, 2016·RNA Biology·Sabine Müller, Bettina Appel
Dec 15, 2017·Nucleic Acids Research·Xiulong Shen, David R Corey
Feb 27, 2018·Chembiochem : a European Journal of Chemical Biology·Linlin YangIvan J Dmochowski
Aug 31, 2018·Scientific Reports·Marta SzabatRyszard Kierzek
Nov 10, 2018·Chemistry : a European Journal·Manuel G RicardoLudger A Wessjohann
Jan 30, 2019·Annual Review of Medicine·C Frank Bennett
Sep 10, 2019·The Journal of Physical Chemistry. B·Parth Chaturvedi, Lela Vuković
Sep 5, 2020·Accounts of Chemical Research·Pawan Kumar, Marvin H Caruthers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.